speb/financial-data huggingface dataset:
IMRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 35985878.00
IMRX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.40
IMRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -14433881.00
IMRX income_statement (quarterly, 2025-06-30) — EBIT: -14757477.00
IMRX income_statement (quarterly, 2025-06-30) — EBITDA: -14665634.00
IMRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 26355498.00
IMRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -61958.00
IMRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -9448240.00
IMRX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4296000.00
IMRX balance_sheet (quarterly, 2025-06-30) — Goodwill: 6690431.00
IMRX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 7026211.00
IMRX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5714608.00
IMRX income_statement (quarterly, 2025-06-30) — Interest Income: 324013.00
IMRX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 324013.00
IMRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 28936037.00
IMRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2116.00
IMRX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
IMRX balance_sheet (quarterly, 2025-06-30) — Leases: 298941.00
IMRX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 3633601.00
IMRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3633601.00
IMRX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 680467.00
IMRX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
IMRX income_statement (quarterly, 2025-06-30) — Net Income: -14433881.00
IMRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -14433881.00
IMRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -14433464.00
IMRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -14433881.00
IMRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -14433881.00
IMRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -14433880.00
IMRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -14433464.00
IMRX income_statement (quarterly, 2025-06-30) — Net Interest Income: 324013.00
IMRX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
IMRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 324013.00
IMRX balance_sheet (quarterly, 2025-06-30) — Net PPE: 4463105.00
IMRX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2116.00
IMRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21909826.00
IMRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -14665634.00
IMRX income_statement (quarterly, 2025-06-30) — Normalized Income: -14433881.00
IMRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -9446124.00
IMRX income_statement (quarterly, 2025-06-30) — Operating Income: -14757477.00
IMRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
IMRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 35987306.00
IMRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1369928.00
IMRX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 209708.00
IMRX income_statement (quarterly, 2025-06-30) — Other Gand A: 1267000.00
IMRX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 335780.00
IMRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 841726.00
IMRX balance_sheet (quarterly, 2025-06-30) — Other Properties: 4735200.00
IMRX balance_sheet (quarterly, 2025-06-30) — Payables: 2395203.00
IMRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5082897.00
IMRX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1827266.00
IMRX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IMRX income_statement (quarterly, 2025-06-30) — Pretax Income: -14433464.00
IMRX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2055.00
IMRX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
IMRX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2116.00
IMRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 91843.00
IMRX income_statement (quarterly, 2025-06-30) — Research And Development: 10454160.00
IMRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -253775199.00
IMRX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 3029000.00
IMRX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
IMRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4296000.00
IMRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 35987306.00
IMRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1524943.00
IMRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 28936037.00
IMRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 21909826.00
IMRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 40056468.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 28936037.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 4000560.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 28936037.00
IMRX income_statement (quarterly, 2025-06-30) — Total Expenses: 14757477.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 11120431.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 12331042.00
IMRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3633601.00
IMRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -14757894.00
IMRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 20238596.00
IMRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 15380300.00
IMRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
IMRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1600274.00
IMRX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1330343.00
IMRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 496653023.00
IMRX income_statement (quarterly, 2025-09-30) — Amortization: 7317.00
IMRX cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 7317.00
IMRX cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 7317.00
IMRX income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 7317.00
IMRX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 0.00
IMRX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 87274.00
IMRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 39670095.00
IMRX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.38
IMRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 26355498.00
IMRX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -7255.00
IMRX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3916329.00
IMRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 63483.00
IMRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 227563077.00
IMRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 227563077.00
IMRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 213192069.00
IMRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -7255.00
IMRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -11977235.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -974893.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 2366906.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 348790.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -213849.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Payable: -974893.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1392013.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -168824.00
IMRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1358130.00
IMRX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 201207579.00
IMRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 63483.00
IMRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 227976432.00
IMRX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 215842304.00
IMRX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4660306.00
IMRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 229101829.00
IMRX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 381760.00
IMRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 381760.00
IMRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9545265.00
IMRX cash_flow (quarterly, 2025-09-30) — Depreciation: 78840.00
IMRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 86157.00
IMRX income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 7317.00
IMRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 86157.00
IMRX income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 7317.00
IMRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 39670095.00
IMRX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.38
IMRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -14964875.00
IMRX income_statement (quarterly, 2025-09-30) — EBIT: -15380300.00
IMRX income_statement (quarterly, 2025-09-30) — EBITDA: -15294143.00
IMRX cash_flow (quarterly, 2025-09-30) — End Cash Position: 227563077.00
IMRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 213192069.00
IMRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -11984490.00
IMRX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4505000.00
IMRX balance_sheet (quarterly, 2025-09-30) — Goodwill: 6690431.00
IMRX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 7018894.00
IMRX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5634589.00
IMRX income_statement (quarterly, 2025-09-30) — Interest Income: 415831.00
IMRX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 415831.00
IMRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 227976432.00
IMRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -7255.00
IMRX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 215842304.00
IMRX balance_sheet (quarterly, 2025-09-30) — Leases: 298941.00
IMRX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3534569.00
IMRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3534569.00
IMRX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 687722.00
IMRX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 215842304.00
IMRX income_statement (quarterly, 2025-09-30) — Net Income: -14964875.00
IMRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -14964875.00
IMRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -14964469.00
IMRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -14964875.00
IMRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -14964875.00
IMRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -14964876.00
IMRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -14964469.00
IMRX income_statement (quarterly, 2025-09-30) — Net Interest Income: 415831.00
IMRX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
IMRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 415831.00
IMRX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3074898.00
IMRX balance_sheet (quarterly, 2025-09-30) — Net PPE: 4304246.00
IMRX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -7255.00
IMRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 220957538.00
IMRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -15294143.00
IMRX income_statement (quarterly, 2025-09-30) — Normalized Income: -14964875.00
IMRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -11977235.00
IMRX income_statement (quarterly, 2025-09-30) — Operating Income: -15380300.00
IMRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
IMRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 63483397.00
IMRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1538752.00
IMRX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 80089.00
IMRX income_statement (quarterly, 2025-09-30) — Other Gand A: 1578000.00
IMRX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 328463.00
IMRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 631297.00
IMRX balance_sheet (quarterly, 2025-09-30) — Other Properties: 4647926.00
IMRX balance_sheet (quarterly, 2025-09-30) — Payables: 1600274.00
IMRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 6260580.00
IMRX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 2822836.00
IMRX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IMRX income_statement (quarterly, 2025-09-30) — Pretax Income: -14964469.00
IMRX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 424663.00
IMRX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
IMRX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -7255.00
IMRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 86157.00
IMRX income_statement (quarterly, 2025-09-30) — Research And Development: 10867983.00
IMRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -268740074.00
IMRX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2927000.00
IMRX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
IMRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4505000.00
IMRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 63483397.00
IMRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1456080.00
IMRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 227976432.00
IMRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 220957538.00
IMRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 241056266.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 227976432.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 3916329.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 227976432.00
IMRX income_statement (quarterly, 2025-09-30) — Total Expenses: 15380300.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 13079834.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 11954437.00
IMRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3534569.00
IMRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -15380706.00
IMRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 219556564.00
IMRX income_statement (annual, 2025-12-31) — +Operating Expense: 59375728.00
IMRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 13751943.00
IMRX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
IMRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
IMRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 1542737.00
IMRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1542737.00
IMRX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1402575.00
IMRX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1402575.00
IMRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 498658072.00
IMRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 498658072.00
IMRX income_statement (annual, 2025-12-31) — Amortization: 29267.00
IMRX income_statement (quarterly, 2025-12-31) — Amortization: 7317.00
IMRX cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 29267.00
IMRX cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 7317.00
IMRX cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 29267.00
IMRX cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 7317.00
IMRX income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 29267.00
IMRX income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 7317.00
IMRX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -155748.00
IMRX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -155748.00
IMRX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 345103.00
IMRX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 89443.00
IMRX balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 44183186.00
IMRX balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 44183186.00
IMRX income_statement (annual, 2025-12-31) — Basic Average Shares: 44011830.00
IMRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 64590066.00
IMRX income_statement (annual, 2025-12-31) — Basic EPS: -1.27
IMRX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.18
IMRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 36144720.00
IMRX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 227563077.00
IMRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -142226.00
IMRX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -123910.00
IMRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3824425.00
IMRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3824425.00
IMRX balance_sheet (annual, 2025-12-31) — Capital Stock: 64648.00
IMRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 64648.00
IMRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 128645025.00
IMRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 128645025.00
IMRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 172831269.00
IMRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 172831269.00
IMRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 226583147.00
IMRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -357523.00
IMRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -88738247.00
IMRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -88719931.00
IMRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -45344595.00
IMRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9840598.00
IMRX cash_flow (annual, 2025-12-31) — Change In Account Payable: -400799.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 73415.00
IMRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2899237.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 990501.00
IMRX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 1114245.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 311397.00
IMRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -280584.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 119520.00
IMRX cash_flow (annual, 2025-12-31) — Change In Payable: -400799.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Payable: 73415.00
IMRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2498438.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1063916.00
IMRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 491837.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1412260.00
IMRX cash_flow (annual, 2025-12-31) — Change In Working Capital: 3823936.00
IMRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 82573.00
IMRX cash_flow (annual, 2025-12-31) — Changes In Cash: 92500305.00
IMRX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -98918052.00
IMRX balance_sheet (annual, 2025-12-31) — Common Stock: 64648.00
IMRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 64648.00
IMRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 218483968.00
IMRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 218483968.00
IMRX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 229518971.00
IMRX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
IMRX balance_sheet (annual, 2025-12-31) — Construction In Progress: 37500.00
IMRX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 37500.00
IMRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3596804.00
IMRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3596804.00
IMRX balance_sheet (annual, 2025-12-31) — Current Assets: 176245954.00
IMRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 176245954.00
IMRX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 397104.00
IMRX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 397104.00
IMRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 397104.00
IMRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 397104.00
IMRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 10073721.00
IMRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10073721.00
IMRX cash_flow (annual, 2025-12-31) — Depreciation: 324517.00
IMRX cash_flow (quarterly, 2025-12-31) — Depreciation: 75889.00
IMRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 353784.00
IMRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 83206.00
IMRX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 29267.00
IMRX income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 7317.00
IMRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 353784.00
IMRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 83206.00
IMRX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 29267.00
IMRX income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 7317.00
IMRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 44011830.00
IMRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 64590066.00
IMRX income_statement (annual, 2025-12-31) — Diluted EPS: -1.27
IMRX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.18
IMRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -56024898.00
IMRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -11580010.00
IMRX income_statement (annual, 2025-12-31) — EBIT: -59375728.00
IMRX income_statement (quarterly, 2025-12-31) — EBIT: -13751943.00
IMRX income_statement (annual, 2025-12-31) — EBITDA: -59021944.00
IMRX income_statement (quarterly, 2025-12-31) — EBITDA: -13668737.00
IMRX cash_flow (annual, 2025-12-31) — End Cash Position: 128645025.00
IMRX cash_flow (quarterly, 2025-12-31) — End Cash Position: 128645025.00
IMRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 226583147.00
IMRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -357523.00
IMRX cash_flow (annual, 2025-12-31) — Free Cash Flow: -45486821.00
IMRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -9964508.00
IMRX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 2093.00
IMRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 2093.00
IMRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 81332.00
IMRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 81332.00
IMRX income_statement (annual, 2025-12-31) — General And Administrative Expense: 17298000.00
IMRX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4490000.00
IMRX balance_sheet (annual, 2025-12-31) — Goodwill: 6690431.00
IMRX balance_sheet (quarterly, 2025-12-31) — Goodwill: 6690431.00
IMRX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 7011578.00
IMRX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 7011578.00
IMRX balance_sheet (annual, 2025-12-31) — Gross PPE: 5663305.00
IMRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 5663305.00
IMRX income_statement (annual, 2025-12-31) — Interest Income: 3039406.00
IMRX income_statement (quarterly, 2025-12-31) — Interest Income: 1861044.00
IMRX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3039406.00
IMRX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1861044.00
IMRX balance_sheet (annual, 2025-12-31) — Invested Capital: 218483968.00
IMRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 218483968.00
IMRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -88738247.00
IMRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -88719931.00
IMRX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 44183186.00
IMRX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 44183186.00
IMRX balance_sheet (annual, 2025-12-31) — Investments And Advances: 44183186.00
IMRX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 44183186.00
IMRX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 229518971.00
IMRX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
IMRX balance_sheet (annual, 2025-12-31) — Leases: 298941.00
IMRX balance_sheet (quarterly, 2025-12-31) — Leases: 298941.00
IMRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3427321.00
IMRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3427321.00
IMRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3427321.00
IMRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3427321.00
IMRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 695545.00
IMRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 695545.00
IMRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 229518971.00
IMRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
IMRX income_statement (annual, 2025-12-31) — Net Income: -56024898.00
IMRX income_statement (quarterly, 2025-12-31) — Net Income: -11580010.00
IMRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -56024898.00
IMRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -11580010.00
IMRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -56024657.00
IMRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -11579234.00
IMRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -56024898.00
IMRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11580010.00
IMRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -56024898.00
IMRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -11580010.00
IMRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -56024898.00
IMRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -11580010.00
IMRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -56024657.00
IMRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -11579234.00
IMRX income_statement (annual, 2025-12-31) — Net Interest Income: 3039406.00
IMRX income_statement (quarterly, 2025-12-31) — Net Interest Income: 1861044.00
IMRX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -88596021.00
IMRX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -88596021.00
IMRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3039406.00
IMRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1861044.00
IMRX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3726266.00
IMRX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -587355.00
IMRX balance_sheet (annual, 2025-12-31) — Net PPE: 4260730.00
IMRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 4260730.00
IMRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -142226.00
IMRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -123910.00
IMRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 211472390.00
IMRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 211472390.00
IMRX income_statement (annual, 2025-12-31) — Normalized EBITDA: -59021944.00
IMRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -13668737.00
IMRX income_statement (annual, 2025-12-31) — Normalized Income: -56024898.00
IMRX income_statement (quarterly, 2025-12-31) — Normalized Income: -11580010.00
IMRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -45344595.00
IMRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -9840598.00
IMRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 2093.00
IMRX income_statement (annual, 2025-12-31) — Operating Income: -59375728.00
IMRX income_statement (quarterly, 2025-12-31) — Operating Income: -13751943.00
IMRX income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
IMRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
IMRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 64648230.00
IMRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 64648230.00
IMRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 3414685.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3414685.00
IMRX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 291513.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 291513.00
IMRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 81332.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 81332.00
IMRX income_statement (annual, 2025-12-31) — Other Gand A: 4863000.00
IMRX income_statement (quarterly, 2025-12-31) — Other Gand A: 1126000.00
IMRX income_statement (annual, 2025-12-31) — Other Income Expense: 311665.00
IMRX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 321147.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 321147.00
IMRX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 283562.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 283562.00
IMRX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 311665.00
IMRX balance_sheet (annual, 2025-12-31) — Other Properties: 4631319.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 4631319.00
IMRX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 44186244.00
IMRX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 44186244.00
IMRX balance_sheet (annual, 2025-12-31) — Payables: 1542737.00
IMRX balance_sheet (quarterly, 2025-12-31) — Payables: 1542737.00
IMRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 5139541.00
IMRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5139541.00
IMRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4245563.00
IMRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4245563.00
IMRX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
IMRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
IMRX income_statement (annual, 2025-12-31) — Pretax Income: -56024657.00
IMRX income_statement (quarterly, 2025-12-31) — Pretax Income: -11579234.00
IMRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 790442.00
IMRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 229832.00
IMRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
IMRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IMRX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -88596021.00
IMRX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -88596021.00
IMRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -142226.00
IMRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -123910.00
IMRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 353784.00
IMRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 83206.00
IMRX income_statement (annual, 2025-12-31) — Research And Development: 42048461.00
IMRX income_statement (quarterly, 2025-12-31) — Research And Development: 9254626.00
IMRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -280320084.00
IMRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -280320084.00
IMRX income_statement (annual, 2025-12-31) — Salaries And Wages: 12435000.00
IMRX income_statement (quarterly, 2025-12-31) — Salaries And Wages: 3364000.00
IMRX cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
IMRX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
IMRX income_statement (annual, 2025-12-31) — Selling General And Administration: 17298000.00
IMRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 4490000.00
IMRX balance_sheet (annual, 2025-12-31) — Share Issued: 64648230.00
IMRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 64648230.00
IMRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 6311135.00
IMRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1637845.00
IMRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 218483968.00
IMRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 218483968.00
IMRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 211472390.00
IMRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 211472390.00
IMRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IMRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (annual, 2025-12-31) — Total Assets: 231985010.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 231985010.00
IMRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 218483968.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 218483968.00
IMRX balance_sheet (annual, 2025-12-31) — Total Debt: 3824425.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 3824425.00
IMRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 218483968.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 218483968.00
IMRX income_statement (annual, 2025-12-31) — Total Expenses: 59375728.00
IMRX income_statement (quarterly, 2025-12-31) — Total Expenses: 13751943.00
IMRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 13501042.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 13501042.00
IMRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 55739056.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 55739056.00
IMRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3427321.00
IMRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3427321.00
IMRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -59375969.00
IMRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -13752719.00
IMRX balance_sheet (annual, 2025-12-31) — Working Capital: 166172233.00
IMRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 166172233.00
IMRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 15334539.00
IMRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
IMRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1453158.00
IMRX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1483977.00
IMRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 500475466.00
IMRX income_statement (quarterly, 2026-03-31) — Amortization: 7317.00
IMRX cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 7317.00
IMRX cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 7317.00
IMRX income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 7317.00
IMRX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -404723.00
IMRX cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 91760.00
IMRX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 41950745.00
IMRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 64658809.00
IMRX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.21
IMRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 128645025.00
IMRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -79930.00
IMRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3730204.00
IMRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 64689.00
IMRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 47321566.00
IMRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 156693623.00
IMRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 180760.00
IMRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -63070775.00
IMRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -18433444.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -89579.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -4778301.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 5434.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -341544.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Payable: -89579.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4867880.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1180990.00
IMRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -6384980.00
IMRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -81323459.00
IMRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 64689.00
IMRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 206518171.00
IMRX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
IMRX balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 0.00
IMRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1996183.00
IMRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 161409158.00
IMRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 412835.00
IMRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 412835.00
IMRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4974250.00
IMRX cash_flow (quarterly, 2026-03-31) — Depreciation: 81402.00
IMRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 88719.00
IMRX income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 7317.00
IMRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 88719.00
IMRX income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 7317.00
IMRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 64658809.00
IMRX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.21
IMRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -13460895.00
IMRX income_statement (quarterly, 2026-03-31) — EBIT: -15334539.00
IMRX income_statement (quarterly, 2026-03-31) — EBITDA: -15245820.00
IMRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 47321566.00
IMRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 180760.00
IMRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -18513374.00
IMRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -241005.00
IMRX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4682000.00
IMRX balance_sheet (quarterly, 2026-03-31) — Goodwill: 6690431.00
IMRX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 7004261.00
IMRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5651474.00
IMRX income_statement (quarterly, 2026-03-31) — Interest Income: 1360404.00
IMRX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1360404.00
IMRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 206518171.00
IMRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -63070775.00
IMRX balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 41950745.00
IMRX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 41950745.00
IMRX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
IMRX balance_sheet (quarterly, 2026-03-31) — Leases: 315297.00
IMRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3317369.00
IMRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3317369.00
IMRX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 789904.00
IMRX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
IMRX income_statement (quarterly, 2026-03-31) — Net Income: -13460895.00
IMRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -13460895.00
IMRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -13460400.00
IMRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -13460895.00
IMRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -13460895.00
IMRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -13460895.00
IMRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -13460400.00
IMRX income_statement (quarterly, 2026-03-31) — Net Interest Income: 1360404.00
IMRX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -62990845.00
IMRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1360404.00
IMRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 4167497.00
IMRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -79930.00
IMRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 199513910.00
IMRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -15245820.00
IMRX income_statement (quarterly, 2026-03-31) — Normalized Income: -13460895.00
IMRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -18433444.00
IMRX income_statement (quarterly, 2026-03-31) — Operating Income: -15334539.00
IMRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
IMRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 64688915.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4715535.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 44191.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -241005.00
IMRX income_statement (quarterly, 2026-03-31) — Other Gand A: 1157000.00
IMRX income_statement (quarterly, 2026-03-31) — Other Income Expense: 513735.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 313830.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 278129.00
IMRX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 513735.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 4546273.00
IMRX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 109372057.00
IMRX balance_sheet (quarterly, 2026-03-31) — Payables: 1453158.00
IMRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3449341.00
IMRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1067883.00
IMRX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
IMRX income_statement (quarterly, 2026-03-31) — Pretax Income: -13460400.00
IMRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 180760.00
IMRX balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
IMRX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -71990845.00
IMRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -79930.00
IMRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 88719.00
IMRX income_statement (quarterly, 2026-03-31) — Research And Development: 10645222.00
IMRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -293780979.00
IMRX income_statement (quarterly, 2026-03-31) — Salaries And Wages: 3525000.00
IMRX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 9000000.00
IMRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4682000.00
IMRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 64688915.00
IMRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1636675.00
IMRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 206518171.00
IMRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 199513910.00
IMRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 214809790.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 206518171.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 3730204.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 206518171.00
IMRX income_statement (quarterly, 2026-03-31) — Total Expenses: 15334539.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 8291619.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 53400632.00
IMRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3317369.00
IMRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -15335034.00
IMRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 156434908.00
IMSR income_statement (annual, 2023-12-31) — +Operating Expense: 13834794.00
IMSR income_statement (annual, 2023-12-31) — +Total Revenue: 18614.00
IMSR balance_sheet (annual, 2023-12-31) — Accounts Payable: 1246347.00
IMSR balance_sheet (annual, 2023-12-31) — Accounts Receivable: 19847.00
IMSR balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -6126438.00
IMSR balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 79770056.00
IMSR income_statement (annual, 2023-12-31) — Amortization: 35478.00
IMSR cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 35478.00
IMSR cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 35478.00